Bank of America
CLOV icon

Bank of America’s Clover Health Investments CLOV Stock Holding History

Bank of America’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Sell
355,014
-16,100
-4% -$54.7K ﹤0.01% 4257
2026
Q1 		$653K Sell
371,114
-71,346
-16% -$155K ﹤0.01% 4755
2025
Q4 		$1.04M Buy
442,460
+309,329
+232% +$845K ﹤0.01% 4505
2025
Q3 		$407K Sell
133,131
-3,879,613
-97% -$11.1M ﹤0.01% 5911
2025
Q2 		$11.2M Buy
4,012,744
+2,748,783
+217% +$9.04M ﹤0.01% 3141
2025
Q1 		$4.54M Buy
1,263,961
+979,733
+345% +$3.93M ﹤0.01% 3907
2024
Q4 		$895K Sell
284,228
-21,040
-7% -$75.2K ﹤0.01% 5125
2024
Q3 		$861K Buy
305,268
+239,655
+365% +$549K ﹤0.01% 5152
2024
Q2 		$80.7K Sell
65,613
-54,098
-45% -$48.5K ﹤0.01% 6349
2024
Q1 		$95K Sell
119,711
-213,120
-64% -$194K ﹤0.01% 6263
2023
Q4 		$317K Buy
332,831
+121,091
+57% +$119K ﹤0.01% 5800
2023
Q3 		$229K Sell
211,740
-294,555
-58% -$350K ﹤0.01% 5833
2023
Q2 		$454K Sell
506,295
-75,186
-13% -$66.7K ﹤0.01% 5346
2023
Q1 		$491K Buy
581,481
+6,483
+1% +$7.1K ﹤0.01% 5388
2022
Q4 		$534K Sell
574,998
-221,475
-28% -$296K ﹤0.01% 5328
2022
Q3 		$1.35M Buy
796,473
+347,106
+77% +$909K ﹤0.01% 4639
2022
Q2 		$962K Buy
449,367
+166,757
+59% +$443K ﹤0.01% 4948
2022
Q1 		$1M Sell
282,610
-85,907
-23% -$249K ﹤0.01% 5229
2021
Q4 		$1.37M Sell
368,517
-171,832
-32% -$1.05M ﹤0.01% 4945
2021
Q3 		$3.99M Sell
540,349
-103,512
-16% -$886K ﹤0.01% 3787
2021
Q2 		$8.57M Sell
643,861
-241,332
-27% -$2.37M ﹤0.01% 2991
2021
Q1 		$6.69M Buy
885,193
+879,062
+14,338% +$9.92M ﹤0.01% 3100
2020
Q4 		$102K Buy
+6,131
New +$68.3K ﹤0.01% 5975

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of America's CLOV Position: Q2 2026 in Review

Bank of America reduced its Clover Health Investments (CLOV) stake by 4.3% in Q2 2026, selling an estimated $54.7K and leaving 355,014 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #4257.

Bank of America first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.2M in Q2 2025. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Bank of America held 355,014 shares of Clover Health Investments worth $1.86M as of Q2 2026.
  • Bank of America sold 16,100 Clover Health Investments shares in Q2 2026, an estimated $54.7K.
  • Clover Health Investments made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4257 holding.
  • Bank of America first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Bank of America's Clover Health Investments position peaked at $11.2M in Q2 2025.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.